Company news

OnKure Therapeutics, Inc. news in 2026

OnKure Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

November 4, 2026

OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference

August 31, 2026

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

August 4, 2026

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

July 1, 2026

OnKure Therapeutics Reports First Quarter 2026 Financial Results

May 5, 2026

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

March 26, 2026

OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

March 12, 2026

Decks in 2026